EUVIMEDDescubrir EUVIMED
FallberichtOpen access · CC BY 4.0

Antileukaemic rescue by dose-dense donor-lymphocyte infusions in T-PLL after allogeneic stem cell transplantation – a case report

Christian Späth, Thomas Neumann, William H Krüger

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05929-z ↗

At a glance

Fallbericht in Annals of Hematology, 2024. Written by Christian Späth and 2 co-authors. Institution: Dept. Internal Medicine C, Haematology, Oncology, Stem Cell Transplantation, University Hospital Greifswald, Palliative Care. Ferdinand Sauerbruch St…. Major MEDLINE topics: Hematopoietic Stem Cell Transplantation, Leukemia, Prolymphocytic, T-Cell, Lymphocyte Transfusion, Blood Donors. 7 references. The full text is freely available (open access, CC BY 4.0). Funded by: Universitätsmedizin Greifswald.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

T-Cell Prolymphocytic Leukaemia (T-PLL) is an aggressive disease with a poor prognosis and only curable by allogeneic stem cell transplantation. We describe the case of a male suffering from T-PLL. Therapy was alemtuzumab followed by an allograft from an unrelated donor. T-PLL relapsed after allogeneic stem cell transplantation. Discontinuation of immunosuppression had no effected and three increasing doses of donor lymphocytes were given within one month. The patient developed acute GvHD of the lover (grade III). GvHD was successfully treated by steroids and ruxolitinib and graft-versus-leukaemia effects induced a complete remission of T-PLL. 18,5 months after transplantation the patient is well and alive without GvHD under immunosuppression with ruxolitinib. Flow cytometry of peripheral blood was negative for residual leukemic cells.

Subjects

MeSH terms (MEDLINE)

Hematopoietic Stem Cell TransplantationLeukemia, Prolymphocytic, T-CellLymphocyte TransfusionBlood DonorsHumansMaleAlemtuzumabAllograftsGraft vs Host DiseaseGraft vs Leukemia EffectNitrilesPyrazolesPyrimidinesTransplantation, Homologous

Author keywords

Allogeneic stem cell transplantationDonor-lymphocyte infusionsGvL-effectsT-Cell prolymphocytic leukaemia

Substances

AlemtuzumabNitrilesPyrazolesPyrimidinesruxolitinib

Authors and institutions

  • Dept. Internal Medicine C, Haematology, Oncology, Stem Cell Transplantation, University Hospital Greifswald, Palliative Care. Ferdinand Sauerbruch Street, 17475, Greifswald, Germany.
  • Dept. Internal Medicine C, Haematology, Oncology, Stem Cell Transplantation, University Hospital Greifswald, Palliative Care. Ferdinand Sauerbruch Street, 17475, Greifswald, Germany. william.krueger@med.uni-greifswald.d…

Funding

  • Universitätsmedizin Greifswald

Cite

APA

Späth, C., Neumann, T., & Krüger, W. H. (2024). Antileukaemic rescue by dose-dense donor-lymphocyte infusions in T-PLL after allogeneic stem cell transplantation – a case report. Annals of Hematology. https://doi.org/10.1007/s00277-024-05929-z

Vancouver

Späth C, Neumann T, Krüger WH. Antileukaemic rescue by dose-dense donor-lymphocyte infusions in T-PLL after allogeneic stem cell transplantation – a case report. Annals of Hematology. 2024. doi:10.1007/s00277-024-05929-z

BibTeX
@article{Spth2024,
  author = {Späth, Christian and Neumann, Thomas and Krüger, William H},
  title = {Antileukaemic rescue by dose-dense donor-lymphocyte infusions in T-PLL after allogeneic stem cell transplantation – a case report},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05929-z}
}
Start for free →